Chemours Co Stock
€11.29
Your prediction
Pros and Cons of Chemours Co in the next few years
Pros
Cons
Performance of Chemours Co vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Chemours Co | 0.940% | 11.591% | 4.172% | -37.376% | 11.591% | -62.681% | -50.055% |
| Quaker Chemical Corp. | 0.820% | 2.479% | 7.826% | -4.615% | 2.479% | - | - |
| RPM International Inc. | -1.670% | 0.000% | -0.552% | -23.729% | 0.000% | 10.429% | 26.761% |
| Albemarle Corp | -1.170% | 12.200% | 28.670% | 59.025% | 12.200% | -33.548% | -7.750% |
Comments
News
This Chemicals Stock Is Down 32% but Just Became a Top 5 Holding After One Fund's $13 Million Bet
New York City-based Alta Fundamental Advisers initiated a new position in The Chemours Company (NYSE:CC), acquiring 800,000 shares valued at an estimated $12.67 million, according to a November 13
Luminus Trims Its Hefty Chemours Position
Luminus Management LLC reduced its stake in The Chemours Company (NYSE:CC) during Q3 2025, selling shares worth an estimated $4.30 million, based on the average quarterly price, according to an SEC
Chemours (CC) Q2 EPS Jumps 53%
Chemours (NYSE:CC), a global chemicals manufacturer known for its fluoroproducts and titanium dioxide pigments, announced its results for Q2 2025 on August 5, 2025. The most notable news was a solid


